This announcement is a separate document:
泰格医药:2023年度股东大会、2024年第二次A股类别股东会议及2024年第二次H股类别股东会议决议的公告
Hangzhou Tigermed Consulting: Announcement of the resolutions of the 2023 Annual General Meeting of Shareholders, the 2024 Second Class A Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.